Wegovy

Pharma

Vanda tests motion sickness drug Nereus in GLP-1 patients

Vanda is kicking off a phase 3 trial to evaluate the ability of its motion sickness drug Nereus to prevent vomiting in those taking a GLP-1 treatment.

Kevin Dunleavy Apr 9, 2026 2:56pm

Man holding remote control in dark room with TV and red and blue lights

J&J's Tremfya retakes TV drug ad spending crown from AbbVie

Apr 8, 2026 11:44am

Analysts pin high hopes early on Lilly's Foundayo launch

Apr 2, 2026 11:42am

UK cost watchdog clears Novo's Wegovy for cardio risk reduction

Apr 1, 2026 9:38am

Flag of India on a pole and billowing in the wind Behind the flag is greenery

Generic versions of Novo's semaglutide launch today in India

Mar 20, 2026 11:27am

Novo Nordisk Wegovy Wegovy Wegovy HD semaglutide Wegovy 72 mg

Novo scores FDA nod for Wegovy HD, plans April launch

Mar 19, 2026 2:11pm